Health Condition 1: L708- Other acne
Conditions
Interventions
Intervention1: SPLIT FACE COMPARATIVE INTERVENTION ON HUMAN PLACENTAL EXTRACT FORMULATION VS PLATELET RICH PLASMA: The study protocol is designed to allow direct intra-individual comparison between tw
Sponsors
Jawaharlal Nehru Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 18 to 45 years Fitzpatrick Skin Types III to V Grade II to IV atrophic acne scars based on standard grading Willingness to participate and sign informed consent form
Exclusion criteria
Exclusion criteria: Active Acne Presence of inflamed comedones, pustules, or nodulocystic lesions Keloidal or Hypertrophic Scar Tendency History of abnormal scarring or collagen overproduction Hematologic Risk Known coagulopathies or ongoing anticoagulant medication Dermatologic Infections Presence of localized cutaneous viral infections (eg: warts) or localized bacterial infections (eg: folliculitis) Pregnancy or Lactation Pregnant or breastfeeding women Known Allergies Hypersensitivity to human placental extract (formulation) or blood products
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Objective: To evaluate the clinical efficacy of microneedling combined with Human placenta extract formulation in comparison with microneedling combined with Autologous Platelet-Rich Plasma in the treatment of atrophic acne scars by implementing a split-face interventional study design. Timepoint: 1 YEAR | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Objective: To compare the safety profile of both treatment modalities by monitoring adverse events, patient tolerance and side effects observed during the course of therapy. Timepoint: 1 YEAR | — |
Countries
India
Contacts
Public ContactDr Bhavana R Doshi
Jawaharlal Nehru Medical College
Outcome results
None listed